Research & Education

The Journal of Thoracic Oncology (JTO) for 2013 has increased its impact factor to 5.8

August 1, 2014

Contact: Rob Mansheim
IASLC Director of Communications
Rob.Mansheim@IASLC.org
(720) 325-2952
FOR IMMEDIATE RELEASE

DENVER – The Journal of Thoracic Oncology (JTO) for 2013 has increased its impact factor from 4.47 in 2012 to 5.8. This makes JTO the 26th oncology journal and 5th in respiratory journals out of 202 and 53 journals respectively.

"I would like to personally thank all of you for your hard work, dedication, devotion and continued support, which make my job fun and easy to do, and continue to enhance the quality of JTO” states JTO Editor, Alex A. Adjei, MD, PhD, FACP.  “Together, I’m hopeful that we will continue to build the quality and reputation of JTO and make it one of the top journals in oncology."

The attached image shows the 5-year trend in impact factor score. The impact factor of an academic journal is a measure reflecting the average number of citations to recent articles published in the journal.

For more information on the JTO and lung cancer please visit www.iaslc.org.

 

-30-

 

About the IASLC:
The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated to the study of lung cancer. Founded in 1974, the association’s membership includes more than 3,800 lung cancer specialists in 80 countries.
To learn more about IASLC please visit http://www.iaslc.org/